83 related articles for article (PubMed ID: 32555534)
1. Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data.
Mesa-Eguiagaray I; Wild SH; Rosenberg PS; Bird SM; Brewster DH; Hall PS; Cameron DA; Morrison D; Figueroa JD
Br J Cancer; 2020 Sep; 123(5):852-859. PubMed ID: 32555534
[TBL] [Abstract][Full Text] [Related]
2. A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.
Chuaychai A; Sriplung H
PLoS One; 2022; 17(3):e0265417. PubMed ID: 35344552
[TBL] [Abstract][Full Text] [Related]
3. Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.
Mullooly M; Murphy J; Gierach GL; Walsh PM; Deady S; Barron TI; Sherman ME; Rosenberg PS; Anderson WF
Eur J Cancer; 2017 Nov; 86():326-333. PubMed ID: 29073583
[TBL] [Abstract][Full Text] [Related]
4. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort.
Shackshaft L; Van Hemelrijck M; Garmo H; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Breast Cancer Res; 2017 Mar; 19(1):22. PubMed ID: 28264697
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype.
Mesa-Eguiagaray I; Wild SH; Bird SM; Williams LJ; Brewster DH; Hall PS; Figueroa JD
Breast Cancer Res Treat; 2022 Jul; 194(2):463-473. PubMed ID: 35648299
[TBL] [Abstract][Full Text] [Related]
6. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
7. Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.
Anderson WF; Rosenberg PS; Petito L; Katki HA; Ejlertsen B; Ewertz M; Rasmussen BB; Jensen MB; Kroman N
Int J Cancer; 2013 Nov; 133(9):2201-6. PubMed ID: 23616071
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
9. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
Sharpe KH; McClements P; Clark DI; Collins J; Springbett A; Brewster DH
Eur J Cancer; 2010 Mar; 46(5):937-43. PubMed ID: 20122823
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
11. Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study.
Andersen ZJ; Jørgensen JT; Elsborg L; Lophaven SN; Backalarz C; Laursen JE; Pedersen TH; Simonsen MK; Bräuner EV; Lynge E
Breast Cancer Res; 2018 Oct; 20(1):119. PubMed ID: 30290832
[TBL] [Abstract][Full Text] [Related]
12. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.
Mazzarella L; Disalvatore D; Bagnardi V; Rotmensz N; Galbiati D; Caputo S; Curigliano G; Pelicci PG
Eur J Cancer; 2013 Nov; 49(17):3588-97. PubMed ID: 23953055
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
14. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
17. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.
Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R
Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the association of area-level socioeconomic deprivation and breast cancer recurrence by oestrogen receptor subtypes in Scotland.
Dunlop HM; Williams LJ; Hall PS; Barber M; Dodds C; Figueroa JD
Breast Cancer Res; 2023 Oct; 25(1):106. PubMed ID: 37784154
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
